Former ZimVie Exec Rebecca Whitney Named CEO of Highridge Medical

MassDevice22:19

ZimVie to Report First Quarter Financial Results on May 8, 2024

PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024

GlobeNewswireApr 25 04:05

Needham: Reiterates that ZimVie (ZIMV.US) holds the rating.

Needham: Reiterates that ZimVie (ZIMV.US) holds the rating.

Zhitong FinanceApr 11 17:50

Needham Reiterates Hold on ZimVie

Needham analyst David Saxon reiterates ZimVie (NASDAQ:ZIMV) with a Hold.

BenzingaApr 11 17:49

Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)

TipRanksApr 11 17:40

ZimVie Expects To Achieve An Annualized Financial Profile Of $455M+ In Net Sales Vs $454.05M Est.; A 15%+ Adjusted EBITDA Margin 1-Year Following The Close Of The Deal

Outlook for ZimVieAs previously communicated, ZimVie expects to achieve an annualized financial profile of $455+ million in Net Sales, and a 15%+ adjusted EBITDA margin(1) one year following the close

BenzingaApr 1 21:37